FibroBiologics enters $6.15M ATM offering with H.C. Wainwright

FibroBiologics, Inc.

Up to $6.15M of common stock may be sold via at-the-market offering with H.C. Wainwright.
H.C. Wainwright receives 3.0% commission on gross proceeds plus $100K legal reimbursement.
Net proceeds used for working capital and general corporate purposes.
Shares will be sold under existing S-3 shelf (Reg. No. 333-284663).
Company not obligated to sell any shares; no assurance on price or timing.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.